Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aeterna Zentaris Intends to File NDA with Respect to Macrilen in Third Quarter of 2017

drugs.comApril 06, 2017

Tag: Aeterna Zentaris , NDA

PharmaSources Customer Service